CN104857304A - Method for preparing medicine for treating biliary ascariasis - Google Patents
Method for preparing medicine for treating biliary ascariasis Download PDFInfo
- Publication number
- CN104857304A CN104857304A CN201510284424.XA CN201510284424A CN104857304A CN 104857304 A CN104857304 A CN 104857304A CN 201510284424 A CN201510284424 A CN 201510284424A CN 104857304 A CN104857304 A CN 104857304A
- Authority
- CN
- China
- Prior art keywords
- grams
- parts
- herba
- radix
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 25
- 201000009361 ascariasis Diseases 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title claims abstract description 6
- 241001316533 Impatiens leptocaulon Species 0.000 claims abstract description 7
- 229940079593 drug Drugs 0.000 claims abstract description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 4
- 229930006000 Sucrose Natural products 0.000 claims abstract description 4
- 210000003445 biliary tract Anatomy 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 8
- 241000242759 Actiniaria Species 0.000 claims description 6
- 241001517299 Bulbophyllum Species 0.000 claims description 6
- 241000345998 Calamus manan Species 0.000 claims description 6
- 241001504128 Cheilanthes Species 0.000 claims description 6
- 241000628997 Flos Species 0.000 claims description 6
- 241000735588 Gaultheria Species 0.000 claims description 6
- 241000272039 Laticauda semifasciata Species 0.000 claims description 6
- 210000003205 muscle Anatomy 0.000 claims description 6
- 235000012950 rattan cane Nutrition 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 238000009827 uniform distribution Methods 0.000 claims description 3
- 239000007919 dispersible tablet Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 5
- 241000415048 Anemone hupehensis Species 0.000 abstract 1
- 241000527163 Aster scaber Species 0.000 abstract 1
- 241000303794 Boehmeria macrophylla Species 0.000 abstract 1
- 241000619366 Caragana sinica Species 0.000 abstract 1
- 241000183302 Cheilanthes chusana Species 0.000 abstract 1
- 241000893856 Dregea sinensis Species 0.000 abstract 1
- 244000252337 Epipremnum pinnatum Species 0.000 abstract 1
- 241000130922 Euonymus sanguineus Species 0.000 abstract 1
- 244000293698 Gaultheria leucocarpa Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000581162 Lepidomicrosorium buergerianum Species 0.000 abstract 1
- 241000522169 Lespedeza Species 0.000 abstract 1
- 235000015511 Liquidambar orientalis Nutrition 0.000 abstract 1
- 241000195954 Lycopodium clavatum Species 0.000 abstract 1
- 241001005394 Parnassia wightiana Species 0.000 abstract 1
- 239000004870 Styrax Substances 0.000 abstract 1
- 244000028419 Styrax benzoin Species 0.000 abstract 1
- 235000000126 Styrax benzoin Nutrition 0.000 abstract 1
- 240000002076 Trema cannabina Species 0.000 abstract 1
- 244000130402 Waltheria indica Species 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 229960004793 sucrose Drugs 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 238000002604 ultrasonography Methods 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000002417 xiphoid bone Anatomy 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 206010056375 Bile duct obstruction Diseases 0.000 description 1
- 206010061695 Biliary tract infection Diseases 0.000 description 1
- 206010008635 Cholestasis Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000034919 Hemobilia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024652 Liver abscess Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010033647 Pancreatitis acute Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 206010056349 Subdiaphragmatic abscess Diseases 0.000 description 1
- 208000003144 Subphrenic Abscess Diseases 0.000 description 1
- 206010044248 Toxic shock syndrome Diseases 0.000 description 1
- 231100000650 Toxic shock syndrome Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 201000003229 acute pancreatitis Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 210000001953 common bile duct Anatomy 0.000 description 1
- 238000007459 endoscopic retrograde cholangiopancreatography Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229940071462 oralone Drugs 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a method for preparing a medicine for treating biliary ascariasis. The method comprises the following steps: crushing 260 g of styrax obassius, 250 g of microsorium buergerianum, 230 g of epipremnum pinnatum, 210 g of impatiens leptocaulon, 200 g of parnassia wightiana, 180 g of boehmeria macrophylla, 180 g of euonymus sanguineus, 160 g of anemone hupehensis, 150 g of doellingeria scaber, 150 g of gaultheria leucocarpa, 130 g of trema cannabina, 120 g of caragana sinica, 120 g of lycopodium clavatum, 120 g of dregea sinensis, 120 g of lespedeza, 110 g of waltheria americana, 100 g of cheilosoria chusana and 80 g of liquorice, screening by using a sieve of 100 meshes, adding 900 g of cane sugar, uniformly mixing, and uniformly allocating into bags of 500 grams to obtain the medicine. Due to the adoption of natural medicines, the medicine for treating biliary ascariasis has the advantages of rapid effect taking, good treatment effect and no toxic or side effect.
Description
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of preparation method for the treatment of the medicine of ascariasis of biliary tract.
Background technology
Ascariasis of biliary tract is a kind of complication the most serious in intestinal ascariasis.It is that the bellyworm motion caused by a variety of causes is active, and the acute upper abdominal pain piercing biliary tract and occur or biliary tract infection.The ascarid bile duct obstruction pierced caused by biliary tract is incomplete, therefore there is jaundice very less, the antibacterial that mainly ascarid is brought into causes bile duct inflammation, and ASCT, liver abscess, subphrenic abscess, biliary peritonitis, acute pancreatitis, hemobilia, toxic shock can be caused, so that dead.
Studying the method for effectively treating ascariasis of biliary tract clinically always.
Summary of the invention
The object of this invention is to provide a kind of preparation method for the treatment of the medicine of ascariasis of biliary tract.
In order to realize object of the present invention, the invention provides a kind of preparation method for the treatment of the medicine of ascariasis of biliary tract, the method comprises the following steps: to take Fructus Styracis obassiae 260 grams, 250 grams, flag, Radix seu caulis epipremni pinnati 230 grams, Impatiens leptocaulon Hook.f. 210 grams, Herba Xanthii 7 200 grams, Radix Boehmeriae Longispicae 180 grams, Bulbophyllum cylinolraceun Linoll. 180 grams, Herba Anemones Hupehensis 160 grams, Rhizoma et Radix Doellingeriae (Herba Doellingeriae) 150 grams, Gaultheria 150 grams, Cortex Trematis Cannabinae Radicis 130 grams, Flos Caraganae Franchetianae 120 grams, Herba Lycopodii 120 grams, pass through 120 grams, muscle rattan, Caulis Seu Folium Lespedezae Bicoloris 120 grams, Laticauda semifasciata 110 grams, Herba Cheilanthes chusane 100 grams and 80 grams, Radix Glycyrrhizae, pulverize, cross 100 mesh sieves, then sucrose 900 grams is added, mixing, uniform distribution loads in 500 bags and get final product.
The present invention also provides the purposes of compositions in the medicine of preparation treatment ascariasis of biliary tract, and described medicine is made up by weight of following bulk drugs: Fructus Styracis obassiae 260 parts, 250 parts, flag, Radix seu caulis epipremni pinnati 230 parts, Impatiens leptocaulon Hook.f. 210 parts, Herba Xanthii 7 200 parts, Radix Boehmeriae Longispicae 180 parts, Bulbophyllum cylinolraceun Linoll. 180 parts, Herba Anemones Hupehensis 160 parts, Rhizoma et Radix Doellingeriae (Herba Doellingeriae) 150 parts, Gaultheria 150 parts, Cortex Trematis Cannabinae Radicis 130 parts, Flos Caraganae Franchetianae 120 parts, Herba Lycopodii 120 parts, pass through 120 parts, muscle rattan, Caulis Seu Folium Lespedezae Bicoloris 120 parts, Laticauda semifasciata 110 parts, Herba Cheilanthes chusane 100 parts and 80 parts, Radix Glycyrrhizae.
Preferably, described medicine can make tablet, dispersible tablet, rapidly dissolving tablet, powder or granule
In the present compositions, Fructus Styracis obassiae, a flag are monarch drug, Radix seu caulis epipremni pinnati, Impatiens leptocaulon Hook.f., Herba Xanthii seven, Radix Boehmeriae Longispicae, Bulbophyllum cylinolraceun Linoll. are ministerial drug, Herba Anemones Hupehensis, Rhizoma et Radix Doellingeriae (Herba Doellingeriae), Gaultheria, Cortex Trematis Cannabinae Radicis, Flos Caraganae Franchetianae, Herba Lycopodii, pass through muscle rattan, Caulis Seu Folium Lespedezae Bicoloris, Laticauda semifasciata, Herba Cheilanthes chusane is adjuvant drug, Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, for making medicine.
Use natural drug in the medicine for the treatment of ascariasis of biliary tract of the present invention, therefore it has instant effect, good effect, the advantage that has no side effect.
Detailed description of the invention
Below by way of the description of detailed description of the invention, the invention will be further described, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, various amendment or improvement can be made, but only otherwise depart from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment powder of the present invention
Take Fructus Styracis obassiae 260 grams, 250 grams, flag, Radix seu caulis epipremni pinnati 230 grams, Impatiens leptocaulon Hook.f. 210 grams, Herba Xanthii 7 200 grams, Radix Boehmeriae Longispicae 180 grams, Bulbophyllum cylinolraceun Linoll. 180 grams, Herba Anemones Hupehensis 160 grams, Rhizoma et Radix Doellingeriae (Herba Doellingeriae) 150 grams, Gaultheria 150 grams, Cortex Trematis Cannabinae Radicis 130 grams, Flos Caraganae Franchetianae 120 grams, Herba Lycopodii 120 grams, pass through 120 grams, muscle rattan, Caulis Seu Folium Lespedezae Bicoloris 120 grams, Laticauda semifasciata 110 grams, Herba Cheilanthes chusane 100 grams and 80 grams, Radix Glycyrrhizae, pulverize, cross 100 mesh sieves, then sucrose 900 grams is added, mixing, uniform distribution loads in 500 bags and get final product.
Experimental example
Diagnostic criteria
Clinical manifestation is: paroxysmal colic under upper right abdomen or xiphoid-process, and especially with " boring top pain ", the catabasis is as ordinary person person.Accompany Nausea and vomiting when an awful ache in the belly, a few patients has vomiting ascaris worm or just ascarid history.Severe symptoms sign is light, only under xiphoid-process and RHC tenderness.The visible cholangiectasis of ultrasonic examination, inside has the polypide that linear is travelling, and parallel light belt of can visiting and be separated by common bile duct or in gallbladder meets biliary tract ascarid diagnosis.ERCP shows ascarid in biliary tract, or direct view under endoscope is shown in that vater's papilla has ascarid incarceration.
Selector close standard of stating ascariasis of biliary tract patient 120 example, wherein man 70 example, female 50 example, the age is 15 years old-28 years old, and the mean age is 19 years old.
Powder obtained in embodiment is used to treat, wherein one day 2 times, oral one bag at every turn, treatment 10 days continuously.
Criterion of therapeutical effect
Recovery from illness: stomachache disappears, and ultrasound diagnosis shows that ascarid is discharged completely; Effective: stomachache disappears, ultrasound diagnosis shows that polypide is broken discharge; Invalid: stomachache continues not alleviate, and ultrasound diagnosis, without improvement, turns surgical intervention.
Result
Through treatment, find that the stomachache of all patients disappears, ultrasound diagnosis shows that ascarid is discharged completely, therefore all meets the criterion of therapeutical effect of recovery from illness.And patient does not find obvious untoward reaction over the course for the treatment of.
Claims (3)
1. treat the preparation method of the medicine of ascariasis of biliary tract for one kind, the method comprises the following steps: to take Fructus Styracis obassiae 260 grams, 250 grams, flag, Radix seu caulis epipremni pinnati 230 grams, Impatiens leptocaulon Hook.f. 210 grams, Herba Xanthii 7 200 grams, Radix Boehmeriae Longispicae 180 grams, Bulbophyllum cylinolraceun Linoll. 180 grams, Herba Anemones Hupehensis 160 grams, Rhizoma et Radix Doellingeriae (Herba Doellingeriae) 150 grams, Gaultheria 150 grams, Cortex Trematis Cannabinae Radicis 130 grams, Flos Caraganae Franchetianae 120 grams, Herba Lycopodii 120 grams, pass through 120 grams, muscle rattan, Caulis Seu Folium Lespedezae Bicoloris 120 grams, Laticauda semifasciata 110 grams, Herba Cheilanthes chusane 100 grams and 80 grams, Radix Glycyrrhizae, pulverize, cross 100 mesh sieves, then sucrose 900 grams is added, mixing, uniform distribution loads in 500 bags and get final product.
2. the purposes of compositions in the medicine of preparation treatment ascariasis of biliary tract, it is characterized in that, described medicine is made up by weight of following bulk drugs: Fructus Styracis obassiae 260 parts, 250 parts, flag, Radix seu caulis epipremni pinnati 230 parts, Impatiens leptocaulon Hook.f. 210 parts, Herba Xanthii 7 200 parts, Radix Boehmeriae Longispicae 180 parts, Bulbophyllum cylinolraceun Linoll. 180 parts, Herba Anemones Hupehensis 160 parts, Rhizoma et Radix Doellingeriae (Herba Doellingeriae) 150 parts, Gaultheria 150 parts, Cortex Trematis Cannabinae Radicis 130 parts, Flos Caraganae Franchetianae 120 parts, Herba Lycopodii 120 parts, pass through 120 parts, muscle rattan, Caulis Seu Folium Lespedezae Bicoloris 120 parts, Laticauda semifasciata 110 parts, Herba Cheilanthes chusane 100 parts and 80 parts, Radix Glycyrrhizae.
3. purposes according to claim 2, is characterized in that, described medicine can make tablet, dispersible tablet, rapidly dissolving tablet, powder or granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510284424.XA CN104857304B (en) | 2015-05-28 | 2015-05-28 | A kind of compositions purposes in the medicine of preparation treatment ascariasis of biliary tract |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510284424.XA CN104857304B (en) | 2015-05-28 | 2015-05-28 | A kind of compositions purposes in the medicine of preparation treatment ascariasis of biliary tract |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104857304A true CN104857304A (en) | 2015-08-26 |
| CN104857304B CN104857304B (en) | 2016-08-24 |
Family
ID=53903767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510284424.XA Expired - Fee Related CN104857304B (en) | 2015-05-28 | 2015-05-28 | A kind of compositions purposes in the medicine of preparation treatment ascariasis of biliary tract |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104857304B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101104071A (en) * | 2007-07-30 | 2008-01-16 | 徐萍儿 | Decoction medicine for treating qi stagnation and blood stasis type biliary ascariasis and preparation method |
| CN101104042A (en) * | 2007-07-30 | 2008-01-16 | 徐萍儿 | Decoction medicine for treating damp-heat type biliary ascariasis and and preparation method |
| CN104474489A (en) * | 2014-11-03 | 2015-04-01 | 吴金霞 | Traditional Chinese medicine preparation for treating biliary tract ascariasis |
-
2015
- 2015-05-28 CN CN201510284424.XA patent/CN104857304B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101104071A (en) * | 2007-07-30 | 2008-01-16 | 徐萍儿 | Decoction medicine for treating qi stagnation and blood stasis type biliary ascariasis and preparation method |
| CN101104042A (en) * | 2007-07-30 | 2008-01-16 | 徐萍儿 | Decoction medicine for treating damp-heat type biliary ascariasis and and preparation method |
| CN104474489A (en) * | 2014-11-03 | 2015-04-01 | 吴金霞 | Traditional Chinese medicine preparation for treating biliary tract ascariasis |
Non-Patent Citations (2)
| Title |
|---|
| 李荣华: "加味自拟胆蛔汤治疗胆道蛔虫症临床观察", 《中国中医基础医学杂志》 * |
| 石小玲；等: "中医治疗蛔虫病近况", 《陕西中医学院学报》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104857304B (en) | 2016-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101041009A (en) | Chinese traditional medicine compound for treating faucitis | |
| CN101168006B (en) | Medicine for treating gastric ulcer | |
| CN102362904A (en) | Chinese medicinal preparation for tonifying spleen and soothing nerves and production method thereof | |
| CN104857304A (en) | Method for preparing medicine for treating biliary ascariasis | |
| CN102526645B (en) | Medicament for treating dysthymic disorder | |
| CN104587310B (en) | Help digestion qi-regulating particle and preparation method thereof | |
| CN103599213B (en) | Medicinal composition for treating bone fracture and preparation method thereof | |
| CN102698065B (en) | Medicine composition for treating primary dysmenorrhea | |
| CN103330779B (en) | Traditional Chinese medicine composition capable of quickly resolving kidney stone | |
| CN102416098A (en) | Medicament for treating upper respiratory tract infection | |
| CN1899387B (en) | Method for preventing and treating child convulsion and its preparing method | |
| CN101396448A (en) | Prescription for treating cervical vertebra disease | |
| CN102274428A (en) | Pharmaceutical composition with effect on treating irritable bowel syndrome and preparation method and application thereof | |
| CN101543615A (en) | Method for preparing Chinese medicinal combination for treating gall-stone | |
| CN102670740A (en) | Drug composition for treating soft tissue injuries and preparation process thereof | |
| CN101112602B (en) | Medicine for treating pharyngitis and method for preparing the same | |
| CN102631404B (en) | Traditional Chinese medicine composition for treating chest impediment | |
| CN103860632A (en) | Drug for treating dermatophytoses and preparation method of drug | |
| CN1554438A (en) | Medicine for strengthening spleen, regulating stomach, promoting digestion and removing stagnated food | |
| CN106492064A (en) | A kind of Chinese medicinal granule for treating children's bacterial infection diarrhoea | |
| CN103610935B (en) | Medicament for treating nausea and vomiting after radiography | |
| CN105596655A (en) | Traditional Chinese medicine electuary for treating infantile pneumonia and preparation method of traditional Chinese medicine electuary | |
| CN104491604B (en) | The Chinese medicine composition and its Chinese medicine preparation of auxiliary treating high blood fat disease, preparation method and application | |
| CN105079590A (en) | Traditional Chinese medicine for treating non-specific ulcerative colitis | |
| CN104958689A (en) | Application of traditional Chinese medicinal composition in preparation of medicine for treating chronic gastritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C53 | Correction of patent of invention or patent application | ||
| CB02 | Change of applicant information |
Address after: No. 18 Qixia Xianlin Avenue District of Nanjing City, Jiangsu province 210046 Applicant after: Jiang Cuiying Address before: 223800 No. 18, Zhenxing Road, Suqian Economic Development Zone, Suqian, Jiangsu Applicant before: Jiang Cuiying |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 223800 SUQIAN, JIANGSU PROVINCE TO: 210046 NANJING, JIANGSU PROVINCE |
|
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhou Shaobo Inventor before: Jiang Cuiying |
|
| COR | Change of bibliographic data | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160620 Address after: 276600 No. 1, building 1, No. 156, Tianqiao Road, Junan County, Shandong, Linyi, 302 Applicant after: Zhou Shaobo Address before: No. 18 Qixia Xianlin Avenue District of Nanjing City, Jiangsu province 210046 Applicant before: Jiang Cuiying |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160824 Termination date: 20170528 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |